Clinical Trials Browser

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden × Decitabine × Clear all

NCT04553393 2020-12-04

Decitabine-primed Tandem CD19/CD20 CAR T Cells Plus Epigenetic Agents in Aggressive r/r B-NHL With Huge Tumor Burden

Phase 1/2 Unknown

Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden